Verve Therapeutics, Inc. - 92539P101
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q3 2025
· Q2 2025
Value (USD)
Total reported value ($000)
$1.37M
QoQ value delta ($000)
-$852M
(-99.84%)
Implied price effect (QoQ)
-49.37%
Shares
Total shares
240,922
QoQ shares delta
-75,744,907
(-99.68%)
Total shares held by funds (by quarter)
Top holders (Q3 2025)
Top 25 only
Full list
Early Q4 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Greenland Capital Management LP | 555 | 49,506 | 0.06% |
| DekaBank Deutsche Girozentrale | 341 | 24,000 | 0.0% |
| Brooklyn Investment Group | 196 | 17,417 | 0.03% |
| IFP Advisors, Inc | 111 | 10,026 | 0.0% |
| OSAIC HOLDINGS, INC. | 37 | 3,344 | 0.0% |
| XTX Topco Ltd | 0 | 124,964 | 0.0% |